DOI: http://dx.doi.org/10.18203/2394-6040.ijcmph20193960

Association between age at onset of multiple sclerosis and vitamin D level in Saudi population

Hossam H. Younis, Abdulrahman H. Alzahrani, Abdulmageed S. Alomar

Abstract


Background: Several studies have shown an association between 25-hydroxyvitamin D (Vitamin D) levels and multiple sclerosis (MS). This study aimed to evaluate association between age at onset of Multiple Sclerosis and vitamin D level in Saudi population.

Methods: This cross-sectional study was performed in the Neurology Department king Fahd Military Hospital Jeddah in the Kingdom of Saudi Arabia (KSA) included 75 patients with MS and 99 healthy controls group matched for gender and age. Comparing vitamin D measurement in multiple sclerosis patients at the time of diagnosis with healthy controls group.

Results: We found no significant association between age at onset of multiple sclerosis and vitamin D level in Saudi population p value (0.723). However we also found that 74.66% of the sample Members who had MS and has a deficient of vitamin D and 83.83% people of the sample members didn’t have MS, but vitamin D was deficient with them.

Conclusions: Study has revealed a high rate of vitamin D deficiency in patients with MS and in the controls group, as well Therese no clear relation to MS, Thus Therese no significant association between age at onset of multiple sclerosis and vitamin D level in Saudi population.


Keywords


Multiple sclerosis, 25-hydroxyvitamin D, Saudi Arabia, Vitamin D deficiency, Age at onset

Full Text:

PDF

References


Yarraguntla K, Seraji N, Lichtman S, Razmjou S, Bao F, Sriwastava S et al. Multiple Sclerosis Fatigue: A Longitudinal Structural MRI and Diffusion Tensor Imaging Study. J Neuroimaging. 2018;28(6):650-5.

Holm R, Højsgaard H, Sellebjerg F, Rode M. Dimethyl fumarate therapy suppresses B cell responses and follicular helper T cells in relapsing-remitting multiple sclerosis. Multiple Sclerosis J. 2018:1352458518790417.

Marck CH, De AM, Brown CR, Neate SL, Taylor KL, Weiland TJ, et al. Health outcomes and adherence to a healthy lifestyle after a multimodal intervention in people with multiple sclerosis: Three year follow-up. PLoS One. 2018;13(5):e0197759.

Evans C, Beland SG, Kulaga S, Wolfson C, Kingwell E, Marriott J, et al. Incidence and prevalence of multiple sclerosis in the Americas: a systematic review. Neuroepidemiology. 2013;40(3):195-210.

Zheng C, He L, Liu L, Zhu J, Jin T. The efficacy of vitamin D in multiple sclerosis: a meta-analysis. Mult Scler Relat Disord. 2018;23:56-61.

Cheong WL, Mohan D, Warren N, Reidpath DD. Multiple Sclerosis in the Asia Pacific Region: A Systematic Review of a Neglected Neurological Disease. Front Neurol. 2018;9:432.

Nazish S, Shahid R, Zafar A, Alshamrani F, Sulaiman AA, Alabdali M, et al. Clinical Presentations and Phenotypic Spectrum of Multiple Sclerosis at a University Hospital in Saudi Arabia. J Clin Neurol. 2018;14(3):359-65.

Marck CH, De AM, Brown CR, Neate SL, Taylor KL, Weiland TJ, et al. Health outcomes and adherence to a healthy lifestyle after a multimodal intervention in people with multiple sclerosis: Three year follow-up. PLoS One. 2018;13(5):e0197759.

Iacopetta K, Collins LE, Buisman FTA, Liu J, Hutchinson AD, Hutchinson MR. Are the protective benefits of vitamin D in neurodegenerative disease dependent on route of administration? A systematic review. Nutr Neurosci. 2018:1-30.

Alharbi FM. Update in vitamin D and multiple sclerosis Neurosciences (Riyadh) 2015;20(4):329-35.

Caccamo D, Ricca S, Currò M, Ientile R. Health risks of hypovitaminosis D: a review of new molecular insights. Int J Mol Sci. 2018;19(3);892.

Holick MF. Vitamin D deficiency. N Engl J Med 2007;357(3):266-81.

Prietl B, Treiber G, Pieber TR, Amrein K. Vitamin D and immune function. Nutrients. 2013;5(7):2502-21.

Mokry LE, Ross S, Ahmad OS, Forgetta V, Smith GD, Goltzman D, et al. Vitamin D and risk of multiple sclerosis. PLoS Med. 2015;12(8):e1001866.

Lonergan R, Kinsella K, Fitzpatrick P, Brady J, Murray B, Dunne C, et al. Multiple sclerosis prevalence in Ireland: relationship to vitamin D status and HLA genotype. J Neurol Neurosurg Psychiatry. 2011;82(3):317-22.

Alsuwadia AO, Farag YM, Al Sayyari AA, Mousa DH, Alhejaili FF, Al-Harbi AS, et al. Prevalence of vitamin D deficiency in Saudi adults.Saudi Med J 2013 Aug;34(8):814-8.

Sheikh A, Saeed Z, Jafri SA, Yazdani I, Hussain SA. Vitamin D levels in asymptomatic adults-a population survey in Karachi, Pakistan. PLoS One. 2012;7(3):e33452.